Brokerages Set The Beauty Health Company (NASDAQ:SKIN) Target Price at $2.40

The Beauty Health Company (NASDAQ:SKIN) has been given a consensus rating of “Reduce” by the seven analysts that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $2.40.

SKIN has been the topic of several recent research reports. Zacks Research cut shares of Beauty Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 21st. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Beauty Health in a research note on Friday, October 31st. TD Cowen raised their price target on Beauty Health from $1.50 to $1.65 and gave the stock a “hold” rating in a research report on Wednesday, January 21st. Wall Street Zen cut shares of Beauty Health from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $1.60 price target on shares of Beauty Health in a report on Wednesday, January 14th.

Institutional Trading of Beauty Health

A number of institutional investors have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio purchased a new stake in Beauty Health in the third quarter valued at $26,000. Atom Investors LP acquired a new stake in shares of Beauty Health in the fourth quarter valued at approximately $29,000. CWM LLC raised its stake in Beauty Health by 232.8% during the fourth quarter. CWM LLC now owns 22,018 shares of the company’s stock worth $31,000 after purchasing an additional 15,402 shares during the period. Franklin Resources Inc. acquired a new position in shares of Beauty Health in the 3rd quarter valued at $31,000. Finally, Ieq Capital LLC acquired a new position in shares of Beauty Health in the 4th quarter worth approximately $33,000. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Beauty Health Stock Down 2.1%

Shares of Beauty Health stock opened at $0.89 on Friday. Beauty Health has a 1 year low of $0.78 and a 1 year high of $2.69. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07. The firm has a market cap of $113.86 million, a price-to-earnings ratio of -4.06 and a beta of 1.16. The company has a 50-day moving average of $1.37 and a 200 day moving average of $1.61.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.